Spanish media company Prisa said on Wednesday it was in talks over the possible sale its Santillana publishing group with U.S. private equity company Rhone Capital.
1 min read · 06 September 2017
Activist investor Land and Buildings, which owns about 2 percent in U.S. real estate investment trust RLJ Lodging Trust, urged the REIT to consider selling itself, Reuters reported.
1 min read · 06 September 2017
Canadian pension fund Caisse de depot et Placement du Quebec (CDPQ) and private equity fund Ardian entered into exclusive talks to acquire a significant stake in airport ground support firm Alvest, the companies said on Wednesday.
1 min read · 06 September 2017
Bain Capital made the first close to its Asia credit fund, raising $557 million as the private equity firm looks to scoop up distressed debt in China and other countries in the region, Reuters reported.
1 min read · 06 September 2017
Singapore’s sovereign wealth fund GIC said this week it would buy a 30 percent stake in BBAM, the world’s largest manager of investments in leased commercial jets, Reuters reported. GIC will buy the stake through partial sales by BBAM’s two existing shareholders, its management team and Canadian private equity firm Onex Corp, GIC said in a statement. Following the purchase, all three parties will have joint minority ownership of the company. GIC did not disclose the financial terms of the deal. BBAM drew a 50 percent investment from Onex in 2012 for US$165 million.
1 min read · 05 September 2017
China’s 3SBio Inc has agreed to buy the contract development and manufacturing unit of Canada’s Therapure Biopharma Inc for US$290 million, part of a push by the Chinese biotech company into the North American market, Reuters reported. The deal, being done through a venture set up by 3SBio and CITIC Private Equity investment, fits with a push by Chinese drug-makers and biopharmaceutical companies to increase their role in the global market. The acquired unit will continue to operate under the Therapure brand and be led by Therapure’s current CEO, Nick Green. Mississauga, Ontario's Therapure was launched in 2008 by Canadian private equity firm Catalyst Capital Group. Catalyst will retain ownership of Therapure’s plasma protein and therapeutic products business as a separate entity.
2 min read · 05 September 2017
China’s 3SBio Inc (1530.HK) has agreed to buy the contract development and manufacturing unit of Canada’s Therapure Biopharma Inc for $290 million, part of a push by the Chinese biotech company into the North American market.
2 min read · 05 September 2017
Eight Roads Ventures, the proprietary investment arm of Fidelity International Ltd, launched its first dedicated China healthcare fund on Tuesday, doubling down bets on the country’s rapidly growing medical sector, Reuters reported.
1 min read · 05 September 2017
Lilium, a German start-up with Silicon Valley-scale ambitions to develop a 5-passenger “flying taxi”, has raised a second, $90 million round of financing from top tech investors, making it one of the best-funded electric aircraft projects to date, Reuters reported.
2 min read · 05 September 2017
Germany’s Merck KGaA is considering selling its $1 billion consumer health unit to meet its financial targets as a decline in its liquid crystal business forces it to review its strategy, Reuters reported.
2 min read · 05 September 2017
